Summary

Global primary cells market is valued approximately at USD 0.97 billion in 2020 and is anticipated to grow with a healthy growth rate of about 12.45% over the forecast period 2021-2027. Primary cells are increasingly gaining popularity to carry out research and development activities as these cells stimulate biological living model closely and are the closest experimental tools which are available without the use of in vivo animal studies. Experiments which are performed using primary cells have potential to deliver more meaningful and relevant data as such cells are closest to “real thing” in terms of both, genotype and phenotype. Rise in prevalence of chronic diseases, rising research and development activities, and increasing investments in cell-based research are some of the factors that are expected to significantly contribute towards the growth of global primary cells market during the forecast period. Primary cells are used in drug screening as well as for the development of different biological compounds such as vaccines, therapeutic proteins, etc. Thus, helps in the prevention of chronic diseases. According to International Diabetes Federation’s report in 2019 diabetes patients across the globe were 463 million whose age was in the range from 20 to 79 years, which is expected to increase 700 million in 2045. This is expected to promote the market growth by increasing the demand and adoption of primary cells. In addition, increasing usage of primary cells in 3D cell culture and increasing investments in drug development and discovery provides lucrative growth opportunities to the market. However, risk of primary cell culture contamination is expected to hamper the growth of global primary cells market during the forecast years.

The regional analysis of the global primary cells market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America accounts for the largest share in terms of market revenue in the global primary cells market over the forecast period 2021-2027. Factors such as increasing number of market players launching new primary cells (human) for research, growing focus on research and development, expansion of the biotechnology and pharmaceutical industries, increasing prevalence of cancer, etc. contributes towards the largest market revenue share of North America. However, Asia Pacific is expected to register the fastest growth rate during the forecast period owing to factors such as increasing prevalence of chronic diseases, government funding for drug development programs, etc.
Major market player included in this report are:
PromoCell GmbH
HemaCare Corporation
Thermo Fisher Scientific, Inc.
Merck KGAA
Lonza
Corning Incorporated
American Type Culture Collection (ATCC)
Cell Biologics, Inc.
Zenbio, Inc.
Stem Cell Technologies, Inc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Origin:
Human primary cells
Animal primary cells
By Type:
Hematopoietic Cells
Dermatocytes
Gastrointestinal Cells
Hepatocytes
Lung Cells
Renal Cells
Heart Cells
Musculoskeletal Cells
Other Primary Cells
By End User:
Life Science Research Companies
Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Primary cells Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

ページTOPに戻る

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Primary Cells Market, by Origin, 2019-2027 (USD Billion)
1.2.2. Primary Cells Market, by Type, 2019-2027 (USD Billion)
1.2.3. Primary Cells Market, by End User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Primary Cells Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Primary Cells Market Dynamics
3.1. Primary Cells Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rise in Prevalence of Chronic Diseases
3.1.1.2. Rising Research and Development activities
3.1.1.3. Increasing Investments in Cell-based Research
3.1.2. Market Restraint
3.1.2.1. Risk of Primary Cell Culture Contamination
3.1.3. Market Opportunities
3.1.3.1. Increasing usage of Primary Cells in 3D Cell Culture
3.1.3.2. Increasing Investments in Drug Development and Discovery
Chapter 4. Global Primary Cells Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Top Investment Opportunities
4.5. Top Winning Strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk assessment: COVID -19 Impact
5.1. Assessment of the Overall Impact of COVID-19 on the industry
5.2. Pre COVID-19 and Post COVID-19 Market Scenario
Chapter 6. Global Primary Cells Market, by Origin
6.1. Market Snapshot
6.2. Global Primary Cells Market by Origin, Performance - Potential Analysis
6.3. Global Primary Cells Market Estimates & Forecasts by Origin 2018-2027 (USD Billion)
6.4. Primary Cells Market, Sub Segment Analysis
6.4.1. Human Primary Cells
6.4.2. Animal Primary Cells
Chapter 7. Global Primary Cells Market, by Type
7.1. Market Snapshot
7.2. Global Primary Cells Market by Type, Performance - Potential Analysis
7.3. Global Primary Cells Market Estimates & Forecasts by Type 2018-2027 (USD Billion)
7.4. Primary Cells Market, Sub Segment Analysis
7.4.1. Hematopoietic Cells
7.4.2. Dermatocytes
7.4.3. Gastrointestinal Cells
7.4.4. Hepatocytes
7.4.5. Lung Cells
7.4.6. Renal Cells
7.4.7. Heart Cells
7.4.8. Musculoskeletal Cells
7.4.9. Other Primary Cells
Chapter 8. Global Primary Cells Market, by End User
8.1. Market Snapshot
8.2. Global Primary Cells Market by End User, Performance - Potential Analysis
8.3. Global Primary Cells Market Estimates & Forecasts by End User 2018-2027 (USD Billion)
8.4. Primary Cells Market, Sub Segment Analysis
8.4.1. Life Science Research Companies
8.4.2. Research Institutes
Chapter 9. Global Primary Cells Market, Regional Analysis
9.1. Primary Cells Market, Regional Market Snapshot
9.2. North America Primary Cells Market
9.2.1. U.S. Primary Cells Market
9.2.1.1. Origin breakdown estimates & forecasts, 2018-2027
9.2.1.2. Type breakdown estimates & forecasts, 2018-2027
9.2.1.3. End User breakdown estimates & forecasts, 2018-2027
9.2.2. Canada Primary Cells Market
9.3. Europe Primary Cells Market Snapshot
9.3.1. U.K. Primary Cells Market
9.3.2. Germany Primary Cells Market
9.3.3. France Primary Cells Market
9.3.4. Spain Primary Cells Market
9.3.5. Italy Primary Cells Market
9.3.6. Rest of Europe Primary Cells Market
9.4. Asia-Pacific Primary Cells Market Snapshot
9.4.1. China Primary Cells Market
9.4.2. India Primary Cells Market
9.4.3. Japan Primary Cells Market
9.4.4. Australia Primary Cells Market
9.4.5. South Korea Primary Cells Market
9.4.6. Rest of Asia Pacific Primary Cells Market
9.5. Latin America Primary Cells Market Snapshot
9.5.1. Brazil Primary Cells Market
9.5.2. Mexico Primary Cells Market
9.6. Rest of The World Primary Cells Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PromoCell GmbH
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. HemaCare Corporation
10.2.3. Thermo Fisher Scientific, Inc.
10.2.4. Merck KGAA
10.2.5. Lonza
10.2.6. Corning Incorporated
10.2.7. American Type Culture Collection (ATCC)
10.2.8. Cell Biologics, Inc.
10.2.9. Zenbio, Inc.
10.2.10. Stem Cell Technologies, Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption